Form 4 for SYNA SYNAPTICS Inc
Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-10 · accession 0001209191-21-064050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-12 | 2021-11-10 | SYNA | WHIMS JAMES L | Dir | S - Sale+OE | $249.29 | -6,216 | 20.4K | -23% | -$1.55M |
| D | 2021-11-12 | 2021-11-10 | SYNA | WHIMS JAMES L | Dir | M - OptEx | $89.29 | +2,302 | 26.7K | +9% | +$205.5K |
| D | 2021-11-12 | 2021-11-10 | SYNA | WHIMS JAMES L | Dir | M - OptEx | $0.00 | -2,302 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-10 | S | D | 3,377 | $248.80 | 23,274 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.12 to $249.11, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2021-11-10 | S | D | 2,839 | $249.88 | 20,435 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.32 to $250, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 3 | Common | Common Stock | 2021-11-10 | M | A | 2,302 | $89.29 | 26,651 | D | — | — | |
| 4 | Derivative | Director Stock Option (Right to Buy) | 2021-11-10 | M | D | 2,302 | $0.00 | 0 | D | $89.29 · — to 2022-10-23 | 2,302 Common Stock | (F3) One-twelfth of the total number of shares subject to the option vested and became exercisable on the 23rd day of each month following the October 23, 2015 date of grant, until fully vested on October 23, 2016. |